Buy MT-II 10mg Peptide: Advanced Melanocortin Receptor Agonist

Elevating Neuroendocrine Research with the MT-II 10mg Peptide

As the global scientific community continues to map the profound complexities of the human neuroendocrine system, the demand for highly stable, synthetically modified molecular tools has never been greater. Enter the MT-II 10mg Peptide (Melanotan II), an industry-leading synthetic analog designed specifically to support rigorous, high-level in-vitro laboratory analysis, receptor-binding assays, and complex cellular modeling.

This highly stable, lyophilized powder represents one of the most fascinating and extensively studied compounds in modern peptide biochemistry. By providing a precise, pre-measured 10mg dosage in a sterile, vacuum-sealed glass vial, the MT-II 10mg Peptide ensures completely standardized baselines across all of your complex cellular assays, melanocyte cultures, and neuro-receptor experiments.

Purchasing this isolated, high-purity cyclic heptapeptide from Orbitrex eliminates the profound variables of structural degradation and molecular contamination often seen in lower-grade biological materials. This provides independent researchers and advanced testing facilities with an incredibly stable, highly reactive tool for investigating cellular signaling cascades, energy homeostasis, and the vast melanocortin receptor network over extended analytical periods.

The Biochemical Origins and Structure of the MT-II 10mg Peptide

To truly understand the profound analytical and research value of the MT-II 10mg Peptide, scientists must first examine its unique biological origins and its brilliant structural engineering.

The MT-II 10mg Peptide is a synthetic analog of naturally occurring alpha-melanocyte-stimulating hormone (α-MSH). In natural biological systems, native α-MSH is a tridecapeptide (a 13-amino-acid chain) produced in the pituitary gland. It is the primary endogenous hormone responsible for stimulating melanogenesis (the production of melanin) and plays heavily heavily in regulating energy homeostasis, sexual arousal, and localized inflammatory responses.

However, native human α-MSH is notoriously unstable in laboratory environments. Like many naturally occurring endogenous hormones, it has an incredibly short half-life, functioning strictly via rapid enzymatic degradation. This makes native α-MSH practically useless for extended in-vitro assays, as it breaks down before researchers can gather meaningful, long-term observational data.

The MT-II 10mg Peptide was engineered in the 1990s at the University of Arizona precisely to solve this biochemical problem. Researchers truncated the native 13-amino-acid chain down to a much shorter, highly potent 7-amino-acid sequence (a heptapeptide). More importantly, they altered the molecular geometry of the compound by introducing a lactam bridge. This cyclic molecular structure effectively “locks” the peptide into its biologically active conformation, making it incredibly resistant to the enzymatic cleavage that destroys native α-MSH.

For the laboratory researcher, this means the MT-II 10mg Peptide can be introduced to a cell culture and observed over a period of many hours or days, providing an incredibly stable, sustained receptor activation that native hormones simply cannot match.

Synergistic Mechanisms: The Melanocortin Receptor Network

The true analytical value of the MT-II 10mg Peptide lies in its nature as a potent, non-selective agonist of the melanocortin receptor (MCR) system. Unlike certain synthetic peptides that target a single, isolated biological pathway, this compound interacts robustly with multiple MCR subtypes, allowing laboratories to study a vast array of downstream cellular responses simultaneously.

When introduced to complex cell cultures, the MT-II 10mg Peptide primarily exerts its effects by binding to G-protein-coupled receptors (GPCRs), subsequently activating the adenylate cyclase pathway and dramatically elevating intracellular levels of cyclic AMP (cAMP). This secondary messenger system is what triggers the specific biological cascades across the different receptor subtypes.

MC1R: Melanogenesis and Cellular Pigmentation Pathways

The most historically recognized function of the MT-II 10mg Peptide is its aggressive agonism of the Melanocortin-1 Receptor (MC1R). MC1R is heavily expressed on the surface of melanocytes—the highly specialized cells primarily responsible for producing pigment.

When researchers apply this peptide to isolated melanocyte cultures, the massive up-regulation of intracellular cAMP leads to the activation of the Microphthalmia-associated transcription factor (MITF). This transcription factor subsequently drives the expression of tyrosinase, the critical, rate-limiting enzyme in the production of melanin.

In advanced in-vitro assays, laboratories utilize the MT-II 10mg Peptide to study the exact stoichiometry and kinetics of eumelanin (dark pigment) synthesis versus pheomelanin (light/red pigment) synthesis. By providing a stable, non-degrading agonist, researchers can map the exact molecular pathways required for cellular pigmentation, which is critical for studying dermatological anomalies and cellular responses to ultraviolet (UV) radiation analogs.

MC3R and MC4R: Energy Homeostasis and Neuroendocrine Signaling

Beyond the skin, the MT-II 10mg Peptide is a critical tool for neuroendocrine laboratories studying the central nervous system. The compound exhibits profound binding affinity for the Melanocortin-3 Receptor (MC3R) and Melanocortin-4 Receptor (MC4R).

These two receptors are primarily located within the central nervous system, particularly in the hypothalamus, and are the fundamental biological controllers of energy homeostasis, feeding behavior, and metabolic rate. In highly specialized nerve-cell cultures or hypothalamic tissue models, introducing the MT-II 10mg Peptide allows scientists to observe the direct suppression of orexigenic (appetite-stimulating) signals and the simultaneous up-regulation of anorexigenic (appetite-suppressing) pathways.

Furthermore, MC4R is heavily implicated in the neurological pathways governing sexual arousal and erectile function. Laboratories utilize this peptide to map the downstream effects of MC4R activation on the peripheral release of nitric oxide (NO), a critical signaling molecule involved in vasodilation.

MC5R: Exocrine Glandular Function

Finally, the MT-II 10mg Peptide interacts with the Melanocortin-5 Receptor (MC5R), which is widely distributed across peripheral tissues but is most notably expressed in exocrine glands (such as the sebaceous glands). In-vitro models focusing on dermatological health and lipid production frequently use this compound to study how MC5R agonism regulates the synthesis and secretion of sebum, providing valuable data for the modeling of acne vulgaris and other glandular dysfunctions.

Verifiable Science Supporting the MT-II 10mg Peptide

The complex biochemical mechanisms, cyclic structural modifications, and profound receptor agonism of melanocortin analogs are extensively documented in modern, peer-reviewed scientific literature. Researchers investigating the fundamental properties of these advanced amino acid chains can find decades of published studies detailing their physiological effects on isolated cell lines, melanocyte cultures, and complex neuroendocrine models.

For highly authoritative, peer-reviewed data regarding the exact receptor-binding profiles, structural mapping, and vast physiological reach of the melanocortin system, researchers are highly encouraged to review extensive physiological studies via the National Center for Biotechnology Information (NCBI). Accessing this foundational research provides a rock-solid, verifiable scientific baseline for laboratories planning to utilize the MT-II 10mg Peptide in their own novel analytical and metabolic experiments.

Ideal In-Vitro Applications for the MT-II 10mg Peptide

Because of its unparalleled multi-pathway approach to the MCR system and its highly stable cyclic structure, the MT-II 10mg Peptide is incredibly versatile and can be deployed in a vast variety of complex in-vitro assays. Laboratories purchasing this advanced compound frequently utilize it for the following primary research models:

1. Melanocyte Proliferation and Pigmentation Assays: Utilizing the compound in isolated human or murine melanocyte cell lines to measure the exact rate of tyrosinase activation, tracking the intracellular conversion of the amino acid tyrosine into visible melanin pigment over extended incubation periods.

2. Receptor Binding Affinity and Competitive Assays: Applying the MT-II 10mg Peptide alongside known MCR antagonists in cell lines expressing precise ratios of MC3R or MC4R to map competitive binding kinetics, calculating precise IC50 (half-maximal inhibitory concentration) values.

3. Hypothalamic Energy Homeostasis Modeling: Subjecting neuroendocrine cell cultures to the peptide to measure the downstream alteration of secondary messenger proteins, observing how the activation of MC4R alters cellular metabolic rates and signaling cascades in a highly controlled, synthetic environment.

4. Western Blotting and cAMP Quantification: Extracting proteins from peptide-treated cell cultures to perform advanced Western blot analysis, precisely quantifying the increased intracellular levels of cyclic AMP and tracking the phosphorylation states of downstream biological targets like the CREB (cAMP response element-binding) protein.

Independent Laboratory Testing and Purity Standards for the MT-II 10mg Peptide

At Orbitrex, we intrinsically understand that your advanced analytical research data is only as accurate, reproducible, and strictly reliable as the raw materials you test. If a complex synthetic peptide contains micro-impurities, excess salts, incomplete cyclic bonds, or degraded amino acid chains, it will instantly introduce unpredictable variables into your research, effectively rendering your expensive analytical data completely useless.

This is precisely why we guarantee that every single batch of our MT-II 10mg Peptide undergoes the most rigorous, independent third-party testing available before it is ever cleared for distribution to the scientific community.

Our primary testing methodologies include High-Performance Liquid Chromatography (HPLC) and Liquid Chromatography-Mass Spectrometry (LC-MS). The HPLC analysis ensures that the molecular weight and retention time of the powder perfectly match the exact profile of pure Melanotan II, successfully separating out any potential biological contaminants, leftover manufacturing solvents, or truncated, non-cyclic peptide fragments.

The Mass Spectrometry confirms the exact 7-amino-acid sequence of the peptide and specifically verifies the successful formation of the critical lactam bridge. Manufacturing a cyclic heptapeptide requires immense biochemical precision; our LC-MS testing guarantees there are no missing, swapped, or malformed links in the molecular structure.

We mandate strictly >99% purity for the MT-II 10mg Peptide, ensuring your laboratory receives uncompromised materials entirely free from binders, heavy metals, synthetic impurities, or leftover manufacturing byproducts. When you source your complex neuroendocrine materials from Orbitrex, you are sourcing absolute, verifiable reliability.

Preparation and Handling of the MT-II 10mg Peptide

Due to the highly fragile molecular structure of synthetic amino acid chains, the proper preparation, reconstitution, and storage of the MT-II 10mg Peptide are absolutely critical to maintaining its analytical efficacy and preventing rapid degradation prior to your planned experiments.

The product is shipped as a lyophilized (freeze-dried) solid powder inside a sterile, vacuum-sealed glass vial. Lyophilization removes the water from the peptide solution under extremely low temperature and pressure, which stabilizes the fragile molecular bonds and allows the MT-II 10mg Peptide to survive the shipping process without rapid degradation or structural collapse.

Reconstitution Protocols

To prepare the MT-II 10mg Peptide for in-vitro application, the powder must be carefully reconstituted into a liquid solution. It is highly recommended to use sterile bacteriostatic water (water containing 0.9% benzyl alcohol) or sterile saline, depending entirely on the specific chemical requirements, osmolality, and sensitivities of your specific cell culture.

When introducing the diluent into the vial containing the MT-II 10mg Peptide, standard sterile laboratory protocols must be strictly observed:

1. Swab the rubber stopper of both the peptide vial and the diluent vial with 70% isopropyl alcohol to ensure complete sterility.

2. Using a sterile syringe, draw the exact desired volume of diluent.

3. Inject the diluent extremely slowly into the peptide vial. Crucial: Direct the stream of the liquid against the inner glass wall of the vial rather than shooting it directly into the lyophilized powder. The force of a direct, high-pressure liquid stream can physically shear the delicate peptide bonds of the MT-II 10mg Peptide, irreparably damaging the molecules before they are ever utilized in your assays.

4. Do not shake the vial under any circumstances. Vigorous shaking will destroy the amino acid sequences. Gently swirl or roll the vial between your fingers until the powder has completely dissolved into a perfectly clear, uniform solution.

Storage Guidelines for the MT-II 10mg Peptide

Maintaining the molecular integrity of the MT-II 10mg Peptide post-reconstitution is paramount to the success, accuracy, and reproducibility of your research.

Unreconstituted (Lyophilized Powder): If you are not utilizing the peptide immediately upon delivery, the dry powder should be stored away from direct sunlight in a completely dry, temperature-controlled environment. For short-term storage (up to 30 days), standard room temperature is acceptable, though refrigeration is always preferred. For long-term storage (up to 24 months), the lyophilized vials must be kept in a dedicated laboratory freezer at -20°C.

Reconstituted (Liquid Solution): Once bacteriostatic water or saline has been introduced to the MT-II 10mg Peptide, the structural degradation clock begins ticking immediately. The reconstituted vial must be immediately refrigerated at 2°C to 8°C (36°F to 46°F). Even when kept at precise, temperature-controlled refrigerated settings, the mixed solution must be utilized in your laboratory assays within 20 to 30 days. Beyond this tight window, the delicate peptide chains will begin to naturally degrade, losing their biological potency, breaking down into unusable fragments, and inevitably skewing your analytical data.

Disclaimer: All products listed by Orbitrex, including the MT-II 10mg Peptide, are sold strictly for in-vitro laboratory research and analytical purposes only. They are not intended for human consumption, ingestion, diagnostic, therapeutic, or agricultural use. Our products are not FDA-approved for human use. Any communications implying human use, tanning, cosmetic application, clinical trials on unapproved human subjects, or bodily injection will result in the immediate cancellation of your account and permanent restriction from our supply chain. All researchers must adhere to their local institutional review board (IRB) guidelines when handling these research materials.